BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23793046)

  • 21. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
    Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of H
    Liu Y; Li W; Duan Y
    J Breath Res; 2019 Apr; 13(3):036005. PubMed ID: 30925484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of lung cancer with volatile markers in the breath.
    Phillips M; Cataneo RN; Cummin AR; Gagliardi AJ; Gleeson K; Greenberg J; Maxfield RA; Rom WN
    Chest; 2003 Jun; 123(6):2115-23. PubMed ID: 12796197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exhaled breath biopsy: a new cancer detection paradigm.
    Abderrahman B
    Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
    [No Abstract]   [Full Text] [Related]  

  • 33. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers.
    Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of breast cancer risk with volatile biomarkers in breath.
    Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S
    Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients.
    Bouza M; Gonzalez-Soto J; Pereiro R; de Vicente JC; Sanz-Medel A
    J Breath Res; 2017 Mar; 11(1):016015. PubMed ID: 28165332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breath Markers of Oxidative Stress in Children with Severe Viral Lower Respiratory Tract Infection.
    Lilien TA; Brinkman P; Fenn DW; van Woensel JBM; Bos LDJ; Bem RA
    Am J Respir Cell Mol Biol; 2024 May; 70(5):392-399. PubMed ID: 38315815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volatile markers of breast cancer in the breath.
    Phillips M; Cataneo RN; Ditkoff BA; Fisher P; Greenberg J; Gunawardena R; Kwon CS; Rahbari-Oskoui F; Wong C
    Breast J; 2003; 9(3):184-91. PubMed ID: 12752626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of breath test for pneumoconiosis: a case-control study.
    Yang HY; Shie RH; Chang CJ; Chen PC
    Respir Res; 2017 Oct; 18(1):178. PubMed ID: 29041938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
    Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
    J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous real-time breath analysis in ruminants: effect of eructation on exhaled VOC profiles.
    Oertel P; Küntzel A; Reinhold P; Köhler H; Schubert JK; Kolb J; Miekisch W
    J Breath Res; 2018 May; 12(3):036014. PubMed ID: 29648550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.